Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 2,670.00
+105.00 (4.09%)
At close: Sep 3, 2026
Progen Market Cap
Progen has a market cap or net worth of 41.44 billion as of September 4, 2026. Its market cap has decreased by -66.53% in one year.
Market Cap
41.44B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,670.00
ChartMarket Cap Chart
Since November 15, 2023, Progen's market cap has decreased from 46.33B to 41.44B, a decrease of -10.56%. That is a compound annual growth rate of -3.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 41.44B | -64.26% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TegoScience | 59.09B |
| KoBioLabs | 57.87B |
| NovMetaPharma | 57.79B |
| QuadMedicine | 55.92B |
| CHOOLIP & SCIENCES | 53.56B |
| Parataxis Korea | 44.13B |
| HLB Pep | 39.94B |
| Kainos Medicine | 35.56B |